Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients (Fit2ThriveMB)

28 septembre 2026 mis à jour par: Siobhan M Phillips, Northwestern University

The purpose of this study is to examine which of four components of a digital health intervention using an App and Fitbit meaningfully contribute to increased physical activity in Metastatic Breast Cancer Patients.

Participants will be asked to:

  • Wear a Fitbit and use an app, use 0 to 3 other components for 24 weeks and attend 6 or 12 coaching coaching calls in the first 12 weeks to increase daily steps.
  • Complete a questionnaire at baseline, week 12 and week 24
  • Complete functional performance test (FPT) via Zoom at baseline, week 12 and week 24
  • Wear a research activity monitor (Accelerometer) for 7 days at baseline, week 12 and week 24

Aperçu de l'étude

Description détaillée

Multiphase Optimization Strategy (MOST) methodology will be used to determine which intervention components or component combinations optimally increase daily steps in a 12-week intervention with a 12-week follow-up. MOST is a framework adapted from engineering that uses highly efficient factorial experiments to evaluate individual, and combined, effects of intervention components to determine which ones can be reduced, eliminated, or replaced to improve efficiency. Insufficiently active people with metastatic breast cancer (MBC) will receive a core intervention consisting of the FIt2ThriveMB app and Fitbit and be randomly assigned to four components, each with two-levels, under consideration for inclusion in the optimized intervention: 1) EHR-integration (on v. off); 2) coaching dose (weekly v. bi-weekly; 3) social+ (on v. off) and 4) goal-setting type (highly tailored v. static). The effects of increasing PA on symptom burden, other intensity activities (i.e. moderate to vigorous, light and sedentary), and functional performance and potential mediators and moderators of component effects will also be examined. Knowledge gained from this study will inform the development of more effective and scalable interventions to improve health and disease outcomes in this population.

Type d'étude

Interventionnel

Inscription (Estimé)

224

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Femelle

La description

Inclusion Criteria:

  • Female sex assigned at birth, age 18 years or older
  • Diagnosed with metastatic breast cancer or locally advanced disease not amenable to surgical resection.
  • Self-report engagement in <150 min/week of moderate to vigorous physical activity
  • Ownership of an Android or iPhone with an up-to-date version of the operating system
  • Internet access to complete assessments
  • Fluency in spoken and written English
  • Willingness to obtain medical clearance to participate.

Exclusion Criteria:

  • Untreated brain metastases
  • Breast cancer with metastases to only the axillary lymph nodes.
  • Self-reported absolute contraindications to exercise (i.e., non-ambulatory, acute myocardial infarction, severe cognitive or functional impairment)
  • Currently pregnant or plans to become pregnant
  • Plans to move out of the United States in next 12 months
  • Current enrollment in another dietary or physical activity trial

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation factorielle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: 1- Core, EHR, Weekly Coaching, Social+, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Expérimental: 2- Core, EHR, Bi-Weekly Coaching, Social+, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Expérimental: 3- Core, EHR, Weekly Coaching, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Expérimental: 4- Core, EHR, Bi-Weekly Coaching, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Expérimental: 5- Core, EHR, Weekly Coaching, Social+, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Expérimental: 6- Core, EHR, Bi-Weekly Coaching, Social+, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Expérimental: 7- Core, EHR, Weekly Coaching, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Expérimental: 8- Core, EHR, Bi-Weekly Coaching, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Expérimental: 9- Core, Weekly Coaching, Social+, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Expérimental: 10- Core, Bi-Weekly Coaching, Social+, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Expérimental: 11- Core, Weekly Coaching, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Expérimental: 12- Core, Bi-Weekly Coaching, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Expérimental: 13- Core, Weekly Coaching, Social+, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Expérimental: 14- Core, Bi-Weekly Coaching, Social+, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Expérimental: 15- Core, Weekly Coaching, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Expérimental: 16- Core, Bi-Weekly Coaching, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change in Steps
Délai: Baseline, 12 and 24 weeks

The ActiGraph accelerometer will be used. Participants will wear the device during all waking hours for 7 consecutive days, except when bathing or swimming, on their non-dominant hip.

Baseline, 12 and 24 weeks

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
ActiGraph measured MVPA
Délai: Baseline, 12 and 24 weeks

Moderate to vigorous physical activity will be measured using the ActiGraph. Participants will wear the device during waking hours for 7 consecutive days, except when bathing or swimming, on their non-dominant hip. Freedson cut points will be used to determine this activity as 2,690-9,642 CPM.

Baseline, 12 and 24 weeks
ActiGraph measured light activity
Délai: Baseline, 12 and 24 weeks

Light intensity physical activity will be measured using the ActiGraph. I Participants will wear the device during waking hours for 7 consecutive days, except when bathing or swimming, on their non-dominant hip. Freedson cutpoints for light activity are defined as Light: 0 - 2,689 CPM.

Baseline, 12 and 24 weeks
ActiGraph measured sedentary behavior
Délai: Baseline, 12 and 24 weeks

Sedentary behavior will be measured using the ActiGraph. Participants will wear the device during waking hours for 7 consecutive days, except when bathing or swimming, on their non-dominant hip. Freedson cutpoints for sedentary behavior are defined as <100 CPM.

Baseline, 12 and 24 weeks
Godin Leisure Time Exercise Questionnaire
Délai: Baseline, 12 and 24 weeks

Participants will be asked to indicate frequency of participation in strenuous (e.g., jogging), moderate (e.g., fast walking), and mild (e.g., easy walking) exercise over the past 7 days and average time spent in each activity. Activity frequencies will be multiplied by 9, 5, and 3 metabolic equivalents, respectively, and summed to create a total leisure time activity score. Weekly minutes of total, light, moderate, and vigorous activity will be calculated by multiplying the frequency and time of each activity. This value will be divided by 7 to obtain daily averages.

Baseline, 12 and 24 weeks
Short Physical Performance Battery (SPPB) Total Score
Délai: Baseline, 12 weeks, 24 weeks

The SPPB score is based on timed measures of gait speed, ability to rise from a chair, and standing balance. Gait speed will be measured using the better of two recorded times over a 4-meter course. Chair stand time will be measured as the time needed to rise five times from a seated position in a chair, with arms folded across the chest. For the balance test, participants will be asked to maintain their feet side-by-side, semi-tandem, and tandem positions for 10 seconds each. Each individual performance measure will be scored according to established cut points and aggregated for a total SPPB score.

Baseline, 12 weeks, 24 weeks
PROMIS Physical Function
Délai: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure physical function with 4 items over the past 7 days. Items are combined using a t-score metric where higher score is better.

Baseline, 12 and 24 weeks
PROMIS Anxiety
Délai: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure Anxiety with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Depression
Délai: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure Depression with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Fatigue
Délai: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure Fatigue with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Ability to Participate in Social Roles and Activities
Délai: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure Ability to Participate in Social Roles and Activities with 4 items over the past 7 days. Items are combined using a t-score metric where the higher score is better.

Baseline, 12 and 24 weeks
PROMIS Sleep Disturbance
Délai: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure sleep disturbance with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Pain Interference
Délai: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure pain interference with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Pain Intensity
Délai: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure pain intensity with 1 item using a scale 1-10 over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 janvier 2027

Achèvement primaire (Estimé)

1 janvier 2031

Achèvement de l'étude (Estimé)

15 juin 2031

Dates d'inscription aux études

Première soumission

18 septembre 2026

Première soumission répondant aux critères de contrôle qualité

18 septembre 2026

Première publication (Réel)

25 septembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

1 octobre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

28 septembre 2026

Dernière vérification

1 septembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • STU00224173
  • R01CA305818 (Subvention/contrat des NIH des États-Unis)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner